Grace Therapeutics Inc.

NASDAQ: GRCE · Real-Time Price · USD
2.93
-0.03 (-1.01%)
At close: Jun 26, 2025, 3:37 PM

Grace Therapeutics Stock Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for GRCE stock have an median target of 12, with a low estimate of 12 and a high estimate of 12. The median target predicts an increase of 309.56% from the current stock price of 2.93.

Target Low Average Median High
Price 12 12 12 12
Change 309.56% 309.56% 309.56% 309.56%

Latest Analyst Insight Report

According to 1 stock analyst, the rating for Grace Therapeutics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Feb 25
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
n/a
Revenue Next Year
450K
from 0
Increased by -%
EPS This Year
-1.16
from -0.79
Increased by -46.8%
EPS Next Year
-0.96
from -1.16
Increased by 17.2%